Clinical Trial Update: Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cetuximab in combination with cisplatin for patients with advanced, persistent, or recurrent cervical cancer; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-03-17